Last reviewed · How we verify

NCT04357197

Closed-loop Control Mean Arterial Pressure In Intensive Care Patients

Withdrawn NA Last updated 23 February 2021
What this trial tests

NA trial testing Closed-loop in Cardiovascular Diseases. Withdrawn.

Timeline
25 September 2020
Primary endpoint
1 December 2020
1 January 2021

Quick facts

Lead sponsorErasme University Hospital
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Start date25 September 2020
Primary completion1 December 2020
Estimated completion1 January 2021

Drugs / interventions tested

Conditions studied

Sponsor

Erasme University Hospital

Who can join

Adults 18 to 99, any sex, with Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this case series is to evaluate the performance of a novel closed-loop (automated) vasopressor administration system that delivers norepinephrine using feedback from standard hemodynamic monitor (EV1000 Monitor) from Edwards Lifesciences (IRVINE, USA) in critically ill patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

Other Erasme University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04357197.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing